» Articles » PMID: 19011540

The Action of Resveratrol, a Phytoestrogen Found in Grapes, on the Intervertebral Disc

Overview
Specialty Orthopedics
Date 2008 Nov 18
PMID 19011540
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design: Basic science, biologic study.

Objective: To determine the potential benefits of using resveratrol (RSV) for intervertebral disc (IVD) matrix repair and regeneration.

Summary Of Background Data: The phytoestrogen RSV is a natural compound found in various plants including grapes and red wines. RSV has been reported to provide a protective effect on articular cartilage in rabbit models for arthritis, but its effect on spine cartilage is unknown. METHODS.: We studied the effect of RSV on bovine IVD cartilage homeostasis by assessing MMP-13 (potent catabolic factor) production, proteoglycan (PG) accumulation and synthesis, and the interaction between RSV and known catabolic factors such as bFGF or IL-1. To understand the molecular mechanisms by which RSV modulates MMP-13 and PG production, we also investigated its downstream target regulatory molecules.

Results: Stimulation of bovine disc cells cultured in monolayer with bFGF or IL-1 augmented the production of MMP-13 and ADAMTS-4 at the transcriptional level and this augmentation was blocked by RSV. Incubation of nucleus pulposus cells with RSV for 21 days significantly increased PG accumulation per cell in a dose-dependent manner, increased PG synthesis, rescued PG losses induced by catabolic reagents bFGF and IL-1, and promoted cell survival to levels seen after incubation with the anabolic protein BMP7 100 ng/mL. Protein-DNA interaction array results suggest that RSV effectively suppresses downstream target molecules of bFGF and IL-1 responsible for oxidative stress, proliferation, and apoptosis.

Conclusion: Resveratrol is a potent anabolic mediator of bovine IVD cartilage homeostasis, revealing its potential as a unique biologic treatment to slow the progression of IVD degeneration. These data suggests RSV may have considerable promise in the treatment of disc degeneration.

Citing Articles

The anti-oxidation related bioactive materials for intervertebral disc degeneration regeneration and repair.

Mai Y, Wu S, Zhang P, Chen N, Wu J, Wei F Bioact Mater. 2024; 45:19-40.

PMID: 39588482 PMC: 11585838. DOI: 10.1016/j.bioactmat.2024.10.012.


Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).

Nguyen C, Coudeyre E, Boutron I, Baron G, Daste C, Lefevre-Colau M PLoS Med. 2024; 21(8):e1004440.

PMID: 39137167 PMC: 11321588. DOI: 10.1371/journal.pmed.1004440.


Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.

Mavrogonatou E, Kletsas D Metabolites. 2024; 14(3).

PMID: 38535306 PMC: 10971879. DOI: 10.3390/metabo14030146.


Low back pain and osteoarthritis pain: a perspective of estrogen.

Pang H, Chen S, Klyne D, Harrich D, Ding W, Yang S Bone Res. 2023; 11(1):42.

PMID: 37542028 PMC: 10403578. DOI: 10.1038/s41413-023-00280-x.


Natural products can modulate inflammation in intervertebral disc degeneration.

Liu Z, Zhu J, Liu H, Fu C Front Pharmacol. 2023; 14:1150835.

PMID: 36874009 PMC: 9978229. DOI: 10.3389/fphar.2023.1150835.


References
1.
Fremont L . Biological effects of resveratrol. Life Sci. 2000; 66(8):663-73. DOI: 10.1016/s0024-3205(99)00410-5. View

2.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K . Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29(8):1039-49. DOI: 10.1002/art.1780290816. View

3.
Raggatt L, Jefcoat Jr S, Choudhury I, Williams S, Tiku M, Partridge N . Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes. Osteoarthritis Cartilage. 2006; 14(7):680-9. DOI: 10.1016/j.joca.2006.01.006. View

4.
Andersson G . Epidemiological features of chronic low-back pain. Lancet. 1999; 354(9178):581-5. DOI: 10.1016/S0140-6736(99)01312-4. View

5.
Pendas A, Uria J, Jimenez M, Balbin M, Freije J, Lopez-Otin C . An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta. 2000; 291(2):137-55. DOI: 10.1016/s0009-8981(99)00225-9. View